Wednesday, 17 May 2017

No difference in rate of adverse cardiovascular events when comparing anticoagulants

(American College of Cardiology) In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI), there was no significant difference in the rate of a composite of death, myocardial infarction and stroke whether they were anticoagulated with bivalirudin or unfractioned heparin, according to a study today in JACC: Cardiovascular Interventions.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2qsqyOS

No comments:

Post a Comment